Medicure Inc. (OTCMKTS:MCUJF – Get Free Report) shares passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.75 and traded as high as $0.8081. Medicure shares last traded at $0.8081, with a volume of 200 shares traded.
Medicure Price Performance
The company has a quick ratio of 0.73, a current ratio of 1.04 and a debt-to-equity ratio of 0.03. The company has a market capitalization of $8.44 million, a PE ratio of -1.72 and a beta of 1.02. The firm’s 50 day simple moving average is $0.75 and its 200 day simple moving average is $0.81.
Medicure (OTCMKTS:MCUJF – Get Free Report) last announced its earnings results on Thursday, May 21st. The company reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.01. The business had revenue of $5.79 million for the quarter, compared to the consensus estimate of $3.63 million. Medicure had a negative net margin of 21.65% and a negative return on equity of 44.34%.
Medicure Company Profile
Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical?care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.
Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.
Recommended Stories
- Five stocks we like better than Medicure
- 2 Stocks Built to Thrive If Inflation Refuses to Fade
- Telecom Earnings Reveal a Sector That Finally Looks Healthier
- Defense Earnings Show Readiness Now and Modernization Ahead
- Why Palantir Investors Aren’t Panicking While the Rest of AI Sells Off
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
